Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Gilda's Club South Jersey

Advertisement

Articles by Gilda's Club South Jersey

In This Together: Help Me Help You

ByGilda's Club South Jersey
August 25th 2016

In This Together: Chemo and Radiation

ByGilda's Club South Jersey
August 25th 2016
Advertisement

Latest Updated Articles

  • In This Together: Chemo and Radiation
    In This Together: Chemo and Radiation

    August 25th 2016

  • In This Together: Help Me Help You
    In This Together: Help Me Help You

    August 25th 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival

2

Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights

3

Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer

4

Frailty Score Shows Link to Toxicity, Mortality Risk With Novel Cancer Therapies

5

Pembrolizumab Improves 7-Year OS in Early-Stage TNBC: KEYNOTE-522 Final Data

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us